Acumen Pharma (ABOS) Company Long-Term Loans and Borrowings

Public company logo of Acumen Pharmaceuticals, Inc (ABOS)

Acumen Pharmaceuticals (ABOS) conducts the development of Alzheimer's disease treatments in Virginia, while drug production is delegated to external CDMO partners to minimize risks. This chart of ABOS quotes demonstrates the asset's dynamics, where the separate_debt_long metric is 0.01. The business relies on colossal demand for monoclonal antibodies, and its environmental strategy includes strict control over reagent disposal and the conservation of water resources.

ABOS Acumen Pharmaceuticals: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Acumen Pharma (ABOS) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price acumenpharm.com|ABOS - Price Target Chart
- market capitalization data:
Market Value Acumen Pharmaceuticals|ABOS - Total Company Value
- book capitalization data:
Net Asset Value per Share Acumen Pharmaceuticals|ABOS - Book Capitalization|Market Capitalization to Book Value Ratio acumenpharm.com|ABOS - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Acumen Pharmaceuticals|ABOS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Acumen Pharmaceuticals, Inc|ABOS - Company Debts|Debt to Book Value Acumen Pharmaceuticals|ABOS - Company Long-Term Debts|Short-Term Debt Acumen Pharmaceuticals
Fundamental company valuation:ABOS (acumenpharm.com)
Mass-produced product of Acumen Pharma

For Acumen Pharmaceuticals (ABOS), a leader in the development of Alzheimer's immunotherapy, financial stability is critical amidst a fierce clinical trial race. This indicator aggregates long-term loans and bond issues, allowing for an assessment of the debt load and default risk; by analyzing the dynamics of the firm's long-term borrowings, an investor can determine how effectively the company finances its research without the threat of catastrophic capital loss.

Direct competitors

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACADIA Corp (ACAD) - Long-Term Debt|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts vikingtherapeutics.com|Company Long-Term Debts SUPN (Supernus)|Company Long-Term Liabilities Catalyst Pharma CPRX|Company Long-Term Liabilities DNLI (Denali Therapeutics Inc)|Harmony Corp - Company Long-Term Debts|BHVN: Company Long-Term Debt|AMLX - Company Long-Term Liabilities|Company Long-Term Debts TRVI|PRAX (Praxis Precision Medicines Inc) - Long-Term Debt|Company Long-Term Debt Anavex Corp (AVXL)|Company Long-Term Indebtedness CeriBell EEG (CBLL)|Prothena (PRTA) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ALEC (alector.com)|Annexon (ANNX) - Company Long-Term Debt|Long-Term Liabilities Omeros Corp OMER|Company Long-Term Debts Neurogene Corp (NGNE)|ACIU - Company Long-Term Loans and Borrowings|VYGR: Company Long-Term Debts|NMRA (neumoratx.com) - Company Long-Term Debts|SCLX - Company Long-Term Debt|Company Long-Term Loans and Borrowings TVGN|Company Long-Term Debt ACOG (Alpha Cognition)|Company Long-Term Liabilities cogrx.com (CGTX)|Company Long-Term Debts IKT (Inhibikase Therapeutics)|Company Long-Term Debts cassavasciences.com SAVA|ASRT: Company Long-Term Debts|COYA - Company Long-Term Liabilities|Company Long-Term Debts VTGN|Long-Term Debt Ovid Therapeutics|CRVO (CervoMed Inc.) - Company Long-Term Liabilities|Company Long-Term Debts Alterity Therapeutics Ltd (ATHE)|Company Long-Term Liabilities Clene Inc.|Amount of Long-Term Liabilities pepgen.com (PEPG)|Company Long-Term Debts JUNS|Long-Term Debt Volume Relmada Corp RLMD|ANVS: Company Long-Term Debts|GRCE - Company Long-Term Liabilities|AIFF: Company Long-Term Debts|KLTO (Klotho Neurosciences) - Company Long-Term Debts|Company Long-Term Debt NeuroSense Therapeutics Ltd|Company Long-Term Debt RVPH|MTVA (MetaVia Inc) - Company Long-Term Debt|Long-Term Debt Volume neuraxis.com (NRXS)|Company Long-Term Debts HSDT (Helius Medical Technologies)|Company Long-Term Debts Passage Bio Inc. PASG|NEUP - Company Long-Term Debts|NERV: Company Long-Term Debt|Company Long-Term Debt ATHA|ADXN (addextherapeutics.com) - Long-Term Debt|ALZN: Company Long-Term Debt|Long-Term Debt Volume CYCN|Company Long-Term Debt Protagenic Therapeutics PTIX|Company Long-Term Indebtedness pasitheaclinics.com (KTTA)|CRGT: Company Long-Term Debts|ATXI - Long-Term Debt|BrainStorm Cell Therapeutics - Company Long-Term Liabilities|CARA: Company Long-Term Debts|Company Long-Term Debt Chromocell Therapeutics Corporation CHRO|ELYM (Eliem Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt ITCI (Intra-Cellular Therapies Inc.)|Long-Term Debt longboardpharma.com|Company Long-Term Debts MRNS|Company Long-Term Debts NKGen Biotech Inc (NKGN)|NeuroBo - Company Long-Term Debts|SAGE - Company Long-Term Liabilities|Synaptogenix, Inc. - Company Long-Term Liabilities|TRVN: Company Long-Term Debts|VIGL (vigilneuro.com) - Company Long-Term Debt|Anew Medical Inc. (WENA) - Company Long-Term Liabilities|Company Long-Term Debts CERE (Cerevel)